Christoph Lengauer
Blueprint Medicines (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, PI3K/AKT/mTOR signaling in cancer, Microtubule and mitosis dynamics, Genetic factors in colorectal cancer, Genomic variations and chromosomal abnormalities
Most-Cited Works
- → Genetic instabilities in human cancers(1998)4,161 cited
- → Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage(1998)2,805 cited
- → Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling(2009)2,067 cited
- → Genetic instability in colorectal cancers(1997)1,989 cited
- → Genes Expressed in Human Tumor Endothelium(2000)1,844 cited
- → Mutations of mitotic checkpoint genes in human cancers(1998)1,478 cited
- → DNMT1 and DNMT3b cooperate to silence genes in human cancer cells(2002)1,242 cited